Table 1.
Baseline clinical characteristics, laboratory values and mortality of the study patients.
| Mild pancreatitis (n=56) | Severe pancreatitis (n=32) | p | |
|---|---|---|---|
| Age, years | 50.4±13.8 | 53.7±16.1 | 0.31 |
| Female n, % | 33(59.8) | 17(53.1) | 0.59 |
| Etiology, n, % | |||
| Gallstone | 37(66.1) | 15(46.9) | 0.07 |
| Others | 19(33.9) | 17(53.1) | |
| Organ failure n, % | - | 2(6.2) | |
| Glucose (mg/dL) | 139.2±64.8 | 172.7±106.1 | 0.07 |
| WBC count (103/L) | 10.597±3894 | 15013±7610 | 0.001 |
| Hgb, g/dL | 13.3±1.5 | 14.7±1.6 | 0.03 |
| PLT count (103/L) | 243±71 | 225±73 | 0.38 |
| Cr, mg/L | 0,9±0,3 | 1,2±0,6 | <0.01 |
| CRP, mg/L | 2.6±3.9 | 5.9±8.5 | 0.10 |
| ALT, U/L | 262.9± 40.1 | 130.1±24.4 | 0.09 |
| AST, U/L | 111±19.1 | 239±40.2 | 0.02 |
| GGT, U/L | 250.7±33.7 | 251±44.7 | 0.72 |
| Amylase, U/L | 1064.2±143.3 | 1615±277.1 | 0.08 |
| Lypase, U/L | 3062.9±608.1 | 4149.9±825.4 | 0.28 |
| Histone 3 | 0.33±0.24 | 0.31±0.19 | 0.65 |
| Histone 4 | 0.59±0.41 | 0.71±1.01 | 0.46 |
| In-hospital mortality | 0 | 2 (6.2%) | 0.14 |
| 30-day mortality | 0 | 2 (6.2%) | 0.14 |